Correlation of Clostridium botulinum type C antitoxin titers in mink and guinea pigs to protection against type C intoxication in mink.
In USA, the potency of commercial vaccines containing Clostridium botulinum type C toxoid is determined by a mink vaccination-challenge assay outlined in the Code of Federal Regulations, Title 9, Part 113.110. A more humane potency test is desired, and this study provides preliminary data in support of a serological assay that correlates post-vaccination antitoxin titers of guinea pigs to vaccine efficacy in mink. Mink and guinea pigs were injected with varying dilutions of a vaccine containing C. botulinum type C toxoid. Blood samples were collected from each animal prior to challenging the mink with type C toxin. Serum antitoxin titers of mink and guinea pigs were measured by a mouse protection test, and the results were compared to the outcome of the toxin challenge in mink. A dose-dependent antitoxin response was observed in guinea pigs vaccinated with the critical dilutions of vaccine bracketing the minimum protective dose in mink. These preliminary data suggest that it may be possible to correlate post-vaccination antitoxin titers in guinea pigs to vaccine efficacy in mink. This correlation could be used as the basis for a more humane potency test for C. botulinum type C toxoids.
Kolbe
D R
DR
Center for Veterinary Biologics, USDA-APHIS-VS, Ames, IA 50010, USA. Donald.R.Kolbe@aphis.usda.gov
Coe Clough
N E
NE
D000818:Animals; D000992:Antitoxins / Q000097:blood*; D001905:Botulinum Toxins / Q000276:immunology* / Q000633:toxicity*; D001906:Botulism / Q000517:prevention & control*; D047968:Clostridium botulinum type C / Q000276:immunology*; D005260:Female; D006168:Guinea Pigs; D051379:Mice; D008907:Mink; D016019:Survival Analysis; D018675:Toxicity Tests / Q000379:methods*; D014121:Toxoids / Q000276:immunology*; D014481:United States
D000992:Antitoxins; D014121:Toxoids; D001905:Botulinum Toxins; C096324:botulinum toxin type C